Abilify Side Effects
Abilify’s common side effects include headaches and insomnia, while severe side effects include seizures and neuroleptic malignant syndrome. Abilify is an antipsychotic drug used in the treatment of conditions such as schizophrenia, bipolar disorder, depression and Tourette’s syndrome.
Article Continues Below
![Abilify pills](https://www.drugwatch.com/wp-content/uploads/abilify-pill.png)
Board-certified physicians medically review Drugwatch.com content to ensure its accuracy and quality.
Drugwatch.com partners with Physicians’ Review Network Inc. to enlist specialists. PRN is a nationally recognized leader in providing independent medical reviews.
Reviewer specialties include internal medicine, gastroenterology, oncology, orthopedic surgery and psychiatry.
Drugwatch.com has been empowering patients for more than a decade
Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.
Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.
The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.
About Drugwatch.com
- Assisting patients and their families since 2008.
- Helped more than 12,000 people find legal help.
- A+ rating from the Better Business Bureau.
- 5-star reviewed medical and legal information site.
Testimonials
"Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her."
- Common side effects
- Blurred vision, constipation, choking or trouble swallowing, drooling, drops in blood pressure when standing up, headache, insomnia, vomiting, weight gain and nausea
- Serious side effects
- Increased cholesterol, insulin resistance, involuntary muscle movements, low white blood cell counts, neuroleptic malignant syndrome, nonalcoholic fatty liver disease and seizures
- Boxed warning
- Older patients with dementia are at an increased risk of death. Individuals using Abilify with antidepressants, especially children, adolescents and young adults, have a higher chance of experiencing suicidal thoughts and behaviors.
Latest Abilify Side Effect Information
As of March 31, 2024, the most reported adverse side effect in the U.S. Food and Drug Administration (FDA) Adverse Events Reporting System was weight gain, followed by anxiety, suicidal ideation and insomnia.
FDA Adverse Events Reporting System (FAERS) Data for Abilify Side Effects | |
---|---|
Total cases reported | 59,662 |
Serious cases (including deaths) | 33,306 |
Deaths | 2,495 |
Disclaimer: Reports sent to the FDA don’t necessarily mean the drug caused an adverse event. Consult a health care professional before stopping or changing medication.
The FDA has received over 59,000 adverse reaction reports combined for five versions of Abilify. This information indicates that over half of all reported adverse reactions are serious. Death occurred in just over 4% of all reported cases.
Boxed Warnings for Abilify Updated
A boxed warning is the highest safety-related warning that the Food and Drug Administration can assign to medications. As of June 5, 2024, Abilify has two boxed warnings.
Older patients with dementia-related psychosis are at an increased risk of death when treated with antipsychotic medications such as Abilify. In clinical trials, older people who were diagnosed with Alzheimer’s disease and treated with atypical antipsychotics like Abilify were 1.6 to 1.7 times more likely to die than those in the control group.
In children, adolescents and young adults, the use of Abilify with antidepressants increases the risk of suicidal thoughts and behaviors. In patients 24 and older, short-term studies of Abilify being used in combination with antidepressants did not show the same adverse effects. For patients aged 65 or older, there was a decrease in the risk of suicidal tendencies when using Abilify with antidepressants.
Age Range | Amount of Cases Compared to Placebo |
---|---|
Less than 18 | 14 additional cases |
18-24 | 5 additional cases |
25-64 | 1 fewer case |
65 and older | 6 fewer cases |
Health care providers should closely monitor patients who begin antidepressant therapy while on Abilify for emerging or worsening suicidal thoughts and behaviors. Likewise, patients using this combination of medications should communicate their symptoms with a health care provider.
Abilify FDA Warnings
On May 3, 2016, the FDA released a warning of potential impulse control problems coinciding with the use of Abilify. Such compulsions include gambling, binge eating, shopping and sex. These uncontrollable urges are rare, and patients have reported that the urges stopped within days to weeks of discontinuation of the medication.
As of March 31, 2024, there are 1,832 reports of gambling or gambling disorder, according to the FDA.
Common Abilify Side Effects
Abilify has a variety of side effects such as restlessness and nausea, but most are mild.
- Akathisia (severe restlessness)
- Anxiety
- Constipation
- Dizziness
- Headache
- Insomnia
- Nausea
- Restlessness
- Vomiting
The side effects on children are not well-researched. Because of this, researchers writing in the Journal of the Canadian Academy of Adolescent Psychiatry recommend that people should consider Abilify as a second-line treatment for children and adolescents with Bipolar Disorder and Schizophrenia.
- Common cold
- Fatigue
- Increased appetite
- Increased urge to sleep
- Muscle twitching
- Weight gain
Patients experiencing disruption from these side effects should be aware that suddenly stopping Abilify may cause withdrawal. Abilify withdrawal symptoms include anxiety, panic attacks and sweating. If you choose to stop Abilify, taper the medication by following your physician’s recommendations.
Serious Side Effects of Abilify
While rare, some Abilify side effects can greatly impact a patient’s quality of life or lead to death.
- Allergic reaction
- Blood disorders like leukopenia and neutropenia
- Body temperature dysregulation
- Compulsive behaviors
- Difficulty swallowing
- Drop in blood pressure when standing
- Falls due to loss of balance
- Metabolic changes
- Neuroleptic malignant syndrome (a rare condition involving stiff muscles and fever)
- Potential for cognitive and motor impairment
- Seizures or convulsions
- Suicidal thoughts or behavior
- Tardive dyskinesia (drug-induced movement disorder)
Neuroleptic Malignant Syndrome
A potentially fatal side effect of antipsychotic drugs, including Abilify, is neuroleptic malignant syndrome. Fever, muscle rigidity, altered mental state and instability are all visible signs of NMS. Although rare, affecting less than .05% of patients according to WebMD, it is important to be aware of these signs of NMS if you take any antipsychotic drug.
Researchers have yet to fully understand its underlying mechanisms, but it’s possible that decreased levels of dopamine cause NMS.
Tardive Dyskinesia
Tardive dyskinesia, or involuntary muscle movements, is a potentially irreversible side effect of Abilify. This condition primarily affects older patients, especially women. The risk of permanent TD increases with long-term use and higher doses of Abilify.
Weight Gain
People taking Abilify may gain 1 to 10 pounds during treatment, and weight gain accounted for about 8% of all reported Abilify side effects. However, significant weight gain, defined as a 7% or more increase in body weight, is uncommon. Some studies found that 13% of patients experienced clinically significant weight gain, while others found it occurred in less than 5% of patients.
While weight gain is possible in adults, this side effect primarily affects adolescents who take aripiprazole, the active drug in Abilify. A 2022 review in Australasian Psychiatry examined 11 studies and found that adolescents, with a mean age of 18, gained an average of 2.7 kg (6 pounds) while on aripiprazole. Those who took the drug for over 12 weeks gained more weight than those who took it for a shorter period.
Impulse Control
In 2022, researchers conducted a review of FAERS reports relating to impulse control, including pathological gambling, compulsive shopping, increased appetite and hypersexuality, dating back to December 2020. This review in the International Journal of Neuropsychopharmacology concluded that aripiprazole was involved in 94% of all the adverse drug reaction reports of impulse control disorders.
Hundreds of people have filed Abilify lawsuits against Bristol-Myers Squibb and Otsuka America Pharmaceutical, the companies behind Abilify. Plaintiffs claim that the impulsive side effects they experienced when taking the drug irreparably altered their lives. In 2016, the FDA warned consumers about a connection between aripiprazole and new and worsening impulse control issues.
Impulse control problems related to Abilify often go away with the reduction or elimination of the medication. If you take Abilify and struggle with impulse control, talk to your doctor about adjusting the dose or stopping the medication. Do not lower your dosage or quit taking your medication without consulting your care provider, as this could lead to withdrawal.
Case Study: Gambling Disorder Claimed After Use of Abilify
According to court records, Joseph Edgar, a resident of Pennsylvania, was prescribed Abilify, an antipsychotic medication, from April 2009 to April 2014.
Development of Compulsive Behaviors
During his use of Abilify, Edgar developed compulsive gambling behaviors. The U.S. label for Abilify did not include adequate warnings about the risk of pathological gambling or other compulsive behaviors until January 2016.
Consequences
Edgar experienced significant financial losses exceeding $36,000, along with emotional and physical distress due to his compulsive gambling. These behaviors ceased after discontinuing the medication.
Lasting Impact
Despite stopping Abilify, court documents claimed Edgar continued to suffer from the neuropsychiatric and economic impacts of the medication, emphasizing the need for comprehensive labeling and adequate patient and physician warnings regarding potential compulsive behaviors.
Abilify Alternatives
Because Abilify is used to treat several conditions, it has many alternatives depending on your needs.
- Caplyta (lumateperone) for schizophrenia and bipolar disorder
- Clozaril (clozapine) for treatment-resistant schizophrenia
- Geodon (ziprasidone) for schizophrenia and bipolar disorder
- Latuda (lurasidone) for schizophrenia and bipolar disorder
- Risperdal (risperidone) for schizophrenia, bipolar disorder and irritability caused by autism
- Saphris (asenapine) for schizophrenia and bipolar disorder
- Seroquel (quetiapine) for schizophrenia, bipolar disorder and depression
- Vraylar (cariprazine) for schizophrenia, bipolar disorder and depression
- Zyprexa (olanzapine) for schizophrenia and bipolar disorder
- Non-drug alternatives such as cognitive-behavioral therapy, diet and exercise
Regulators and public health agencies stress the importance of careful monitoring and individualized treatment plans, particularly in vulnerable populations such as older adults and those with pre-existing conditions.
If Abilify does not seem to decrease your symptoms or you experience side effects, speak with your care provider about changing your dosage or switching to a different medication.
Editor Lindsay Donaldson contributed to this article.
Calling this number connects you with a Drugwatch.com representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch.com's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.